Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Long-term Objective A

yellow dot 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Projects Found: 14
Total Funding: 3713783
Records
Project Title Funding Funding Institution

Project Title

Randomized phase 2 trial of RAD001 (an MTOR inhibitor) in patients with tuberous sclerosis complex
$65,000

Funding

65000

Institution

Boston Children's Hospital

Project Title

A multi-site double-blind placebo-controlled trial of memantine vs. placebo in children with autism
$0

Funding

0

Institution

Holland Bloorview Kids Rehabilitation Hospital

Project Title

Testing the use of helminth worm ova in treating autism spectrum disorders
$124,802

Funding

124802

Institution

Montefiore Medical Center

Project Title

Trial of a glutamate antagonist in the treatment of OCD and autistic disorders
$33,959

Funding

33959

Institution

National Institutes of Health

Project Title

Association of cholinergic system dysfunction with autistic behavior in fragile X syndrome: Pharmacologic and imaging probes
$92,469

Funding

92469

Institution

Stanford University

Project Title

Randomized controlled trial of oxytocin treatment for social deficits in children with autism
$50,600

Funding

50600

Institution

Stanford University

Project Title

Controlled trial of sertraline in young children with Fragile X Syndrome
$285,970

Funding

285970

Institution

University of California, Davis

Project Title

ACE Center: Augmenting language interventions for ASD: A translational approach
$281,072

Funding

281072

Institution

University of California, Los Angeles

Project Title

New experimental medicine studies: Fast-Fail Trials in autism spectrum disorders
$115,889

Funding

115889

Institution

University of California, Los Angeles

Project Title

Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial
$0

Funding

0

Institution

University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School

 
Back to Top